• No se han encontrado resultados

TítuloA randomized clinical trial to determine the effect of angiotensin inhibitors reduction on creatinine clearance and haemoglobin in heart failure patients with chronic kidney disease and anaemia

N/A
N/A
Protected

Academic year: 2020

Share "TítuloA randomized clinical trial to determine the effect of angiotensin inhibitors reduction on creatinine clearance and haemoglobin in heart failure patients with chronic kidney disease and anaemia"

Copied!
13
0
0

Texto completo

Loading

Figure

Table 1. Characteristics of patients included in the study by group
Table 2. Changes in the parameters studied during follow-up in the treatment and control groups
Figure 1. Survival probability by study group
Table 3. Cox regression analysis to predict mortality in patients with heart failure adjusting for different covariables

Referencias

Documento similar

FIND-CKD: a ran- domized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia. Bailie GR, Larkina M,

Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart

Kopple, “Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients,” Clinical Journal of the American Society of Nephrology,

This study is part of a bigger and ambitious research project with the general aim to achieve a standardized and unique self-reported scale in Spanish-speaking population to

The patients with ADPKD included in the study had worse renal function (worse mean estimated by glomerular filtration rate [eGFR], more in patients with CKD stage 4) and

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy (CREDENCE), Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients with Chronic Kidney

A Study on the Relationship between Serum Beta 2-Microglobulin Levels, Underlying Chronic Kidney Disease, and Peripheral Arterial Disease in High-Vascular-Risk

The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage